Material Type

• Blood (whole) (5)
• Buffy coat (1)
• Dried whole blood (3)
• Host genomic DNA (Derivative) (1)
• Isolated peripheral blood mononuclear cells (non viable) (1)
• Isolated peripheral blood mononuclear cells (viable) (3)
• Nasal washing (1)
• Other (3)
• Pathogen DNA (Derivative) (2)
• Plasma (double spun) (3)
• Plasma (single spun) (5)
• Saliva (3)
• Serum (9)
• Solid tissue (non viable) (1)
• Sputum (1)
• Stool (4)
• Swab medium (4)
• Urine (first morning) (1)
• Urine (random) (3)

Microscopic Assessment

• Affected (3)
• Not applicable (11)

Storage Temperature

• RT (2)
• -35°C to -18°C (3)
• -85°C to -60°C (12)
• Liquid nitrogen (3)

Preservation Type

• N/A (3)

Associated Data

• Biomarker datasets (4)
• Clinical records (8)
• Followup records (7)
• Freezer temperature logs (6)
• Genomic datasets (4)
• Imaging data (1)
• Microbiological results (3)
• Participant Ethnicity (3)
• Physiological/biochemical measurements (4)
• Pre-analytical data (5)
• Primary care records (1)
• Psychological data (1)
• Quality indicators (5)
• Survey data (6)
• Treatment records (4)

Timeframe

• Immediate (1)
• 0 - 3 months (8)
• 3 - 6 months (4)
• > 6 months (3)

Participant Count

• 1 - 10 (2)
• 11 - 100 (5)
• 101 - 500 (11)
• 501 - 1000 (1)
• 1001 - 3000 (1)
• 3001 - 5000 (1)

Sex

• Female (1)
• Unknown (1)
• Both sexes (12)
• Undifferentiated (1)

Age Range

• Infant (1 month - 2 years) (1)
• Young child (2 - 6 years) (3)
• Child (6 - 12 years) (4)
• Adolescent (12 - 18 years) (3)
• Young adult (18 - 40 years) (8)
• Adult (> 40 years) (7)
• Data not recorded (2)

Biobank Services

• Ability to recontact (5)
• Access to the full pathology archive (2)
• Cell culture (5)
• Data analytics (5)
• Digital imaging (3)
• Immunohistochemistry - scoring (1)
• Immunohistochemistry - staining (1)
• Infectious strain isolation (2)
• Molecular Extractions (3)
• Nucleic acid extraction (5)

Collection Type

• (1)
• Case-control (2)
• Cohort (3)
• Cross-sectional (3)
• Disease specific (5)
• Longitudinal (2)

Consent Restriction

• No Commercial restriction (13)
• No Disease area restriction (13)
• No Genetic analysis restriction (13)
• No Human genetic analysis restriction (10)
• No restrictions (4)
• No Project specific restriction (10)
• No Scope of use restriction (8)

Collection Status

• Completed (5)
• In progress (8)
• Not-started (3)

Access Condition

• Open to applicants (8)
• Open in response to specific calls (1)
• Open only through collaboration (6)
• Data access only (1)
• Access restricted at present (1)

Country

• Belgium (1)
• France (1)
• India (1)
• Kenya (1)
• Peru (1)
• Qatar (1)
• South Africa (1)
• Spain (1)
• Sudan (1)
• Switzerland (1)
• Uganda (1)
• United States (2)

County